Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEEFG
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,388
Award facts
- Contract value 100% obligated
- $15,387.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $15,387.92 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This firm fixed-price delivery order, issued on January 26, 2026, with an ultimate completion date of January 27, 2026, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy that established multiple regional prime vendor contractors to supply the Department of Defense with pharmaceutical products and medical consumables.
DMS Pharmaceutical Group's $499.999 billion PPV-G GEN V prime vendor contract, awarded in November 2025 with a completion date of December 31, 2036, authorizes the company to distribute a comprehensive range of pharmaceutical products including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals to military healthcare facilities worldwide. The contractor's substantial federal contracting activity and diverse product portfolio—spanning oncology treatments, immunosuppressants, emergency medications, and routine pharmaceuticals—positions DMS Pharmaceutical Group as a critical supplier within the federal military medical supply chain, with the current delivery order representing one of numerous transactions issued under this strategic framework.
Quick answers
Who was awarded contract SPE2DU26FEEFG?
SPE2DU26FEEFG was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DU26FEEFG worth?
The government has obligated $15,388 on SPE2DU26FEEFG.
Is contract SPE2DU26FEEFG an order under another contract?
Yes. SPE2DU26FEEFG is a delivery order under SPE2DU25D9439, an indefinite delivery contract.
Was contract SPE2DU26FEEFG competed?
The extent of competition for SPE2DU26FEEFG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award